Figure 1
From: Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Serum miR-223-3p concentration: miR-223-3p concentration in sera of patients with a diagnosis of mild cognitive impairment (MCI, n = 35), Alzheimer’s Disease (AD, n = 40), or Parkinson’s Disease (PD, n = 28) and in healthy controls (HC, n = 40). Row data were normalized with reference miRNA (C.el.miR-39) and ΔΔCt method was used to calculate the fold change relative to HC. Bars represent median fold change and interquartile range (25th−75th percentile); statistical significances are indicated. *p < 0.001.
